Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Working Capital/Sales

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 17.227.287.747.993.97

What is the latest Working Capital/Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest Working Capital/Sales ratio of GLENMARK PHARMACEUTICALS is 17.22 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar202417.22
Mar20237.28
Mar20227.74
Mar20217.99
Mar20203.97

How is Working Capital/Sales of GLENMARK PHARMACEUTICALS Trending?

Years Working Capital/Sales % Change
Mar2024 17.22
136.54
Mar2023 7.28
-5.94
Mar2022 7.74
-3.13
Mar2021 7.99
101.26
Mar2020 3.97 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Working Capital/Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹62,597.6 Cr 21.3% 32.9% 58.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,580.0 Cr 0.6% -0.4% 4.7% Stock Analytics
DIVIS LABORATORIES ₹180,069.0 Cr -2.2% 1.7% 47.3% Stock Analytics
CIPLA ₹119,919.0 Cr -0.2% -1.4% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹115,310.0 Cr 2.5% 4.8% 12.2% Stock Analytics
DR REDDYS LABORATORIES ₹104,402.0 Cr -2.6% -8.1% -4.9% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

21.3%

32.9%

58.2%

SENSEX

-1.4%

0.7%

2.4%


You may also like the below Video Courses